Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: DRTS) | Delayed: 12.99 -0.49 (3.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.48 | 52 Week High | $ | |||
| Open | $13.25 | 52 Week Low | $ | |||
| Day High | $13.46 | P/E | N/A | |||
| Day Low | $12.95 | EPS | $ | |||
| Volume | 195,644 | |||||
